tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
MAIA Biotechnology doses first patient in Phase 3 trial of ateganosine in NSCLC
PremiumThe FlyMAIA Biotechnology doses first patient in Phase 3 trial of ateganosine in NSCLC
1M ago
MAIA Biotechnology CEO, board members acquire company shares
Premium
The Fly
MAIA Biotechnology CEO, board members acquire company shares
1M ago
MAIA Biotechnology Advances NSCLC Treatment with Ateganosine
Premium
Company Announcements
MAIA Biotechnology Advances NSCLC Treatment with Ateganosine
1M ago
MAIA Biotechnology CEO presents at Smart Diaspora 2025
PremiumThe FlyMAIA Biotechnology CEO presents at Smart Diaspora 2025
2M ago
MAIA Biotechnology Presents Posters at Cancer Conference
Premium
Company Announcements
MAIA Biotechnology Presents Posters at Cancer Conference
2M ago
MAIA Biotechnology’s Phase III Study: A New Hope for Advanced NSCLC Treatment
Premium
Company Announcements
MAIA Biotechnology’s Phase III Study: A New Hope for Advanced NSCLC Treatment
3M ago
MAIA Biotechnology Announces Private Placement Agreement
PremiumCompany AnnouncementsMAIA Biotechnology Announces Private Placement Agreement
3M ago
MAIA Biotechnology to sell 603,769 shares at $1.22 in private placement
Premium
The Fly
MAIA Biotechnology to sell 603,769 shares at $1.22 in private placement
3M ago
MAIA Biotechnology Adopts New Digital Asset Strategy
Premium
Company Announcements
MAIA Biotechnology Adopts New Digital Asset Strategy
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100